Tags

Type your tag names separated by a space and hit enter

A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.
Eur J Neurol. 2007 Apr; 14(4):413-7.EJ

Abstract

A PARK8 form of Parkinson's disease (PD) is caused by a novel gene, leucine-rich repeat kinase 2 (LRRK2), and a single mutation G2019S was found in a proportion of LRRK2-associated cases of diverse ethnic origins. We performed the LRRK2 G2019S mutation analysis in 304 Russian patients with PD, including 291 sporadic and 13 autosomal dominant cases. The frequency of the LRRK2 G2019S was 0.7% amongst the sporadic patients (2/291) and 7.7% amongst familial PD (1/13). The mutation was also found in three unaffected relatives and absent in 700 control chromosomes. One patient carrying the LRRK2 G2019S was found earlier to have an additional mutation, a heterozygous duplication of exon 5 of the parkin gene. All patients carrying the LRRK2 G2019S exhibited typical levodopa-responsive parkinsonism, and severe levodopa-induced dyskinesia was observed in the patient carrying the LRRK2 and parkin mutations. There was notable variability in ages of the disease onset in G2019S carriers not explained by APOE genotypes. Two subsets of G2019S-positive patients had different PARK8 haplotypes suggesting that the LRRK2 G2019S in Russian patients had arisen independently on different chromosomes. Identification of common LRRK2 mutations in some PD patients without an overt family history has notable implications for genetic counseling.

Authors+Show Affiliations

Department of Neurogenetics, Institute of Neurology, Russian Academy of Medical Sciences, Moscow, Russia. s-illario@mtu-net.ruNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

17388990

Citation

Illarioshkin, S N., et al. "A Common Leucine-rich Repeat Kinase 2 Gene Mutation in Familial and Sporadic Parkinson's Disease in Russia." European Journal of Neurology, vol. 14, no. 4, 2007, pp. 413-7.
Illarioshkin SN, Shadrina MI, Slominsky PA, et al. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia. Eur J Neurol. 2007;14(4):413-7.
Illarioshkin, S. N., Shadrina, M. I., Slominsky, P. A., Bespalova, E. V., Zagorovskaya, T. B., Bagyeva, G. K. h., Markova, E. D., Limborska, S. A., & Ivanova-Smolenskaya, I. A. (2007). A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia. European Journal of Neurology, 14(4), 413-7.
Illarioshkin SN, et al. A Common Leucine-rich Repeat Kinase 2 Gene Mutation in Familial and Sporadic Parkinson's Disease in Russia. Eur J Neurol. 2007;14(4):413-7. PubMed PMID: 17388990.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia. AU - Illarioshkin,S N, AU - Shadrina,M I, AU - Slominsky,P A, AU - Bespalova,E V, AU - Zagorovskaya,T B, AU - Bagyeva,G Kh, AU - Markova,E D, AU - Limborska,S A, AU - Ivanova-Smolenskaya,I A, PY - 2007/3/29/pubmed PY - 2007/6/15/medline PY - 2007/3/29/entrez SP - 413 EP - 7 JF - European journal of neurology JO - Eur J Neurol VL - 14 IS - 4 N2 - A PARK8 form of Parkinson's disease (PD) is caused by a novel gene, leucine-rich repeat kinase 2 (LRRK2), and a single mutation G2019S was found in a proportion of LRRK2-associated cases of diverse ethnic origins. We performed the LRRK2 G2019S mutation analysis in 304 Russian patients with PD, including 291 sporadic and 13 autosomal dominant cases. The frequency of the LRRK2 G2019S was 0.7% amongst the sporadic patients (2/291) and 7.7% amongst familial PD (1/13). The mutation was also found in three unaffected relatives and absent in 700 control chromosomes. One patient carrying the LRRK2 G2019S was found earlier to have an additional mutation, a heterozygous duplication of exon 5 of the parkin gene. All patients carrying the LRRK2 G2019S exhibited typical levodopa-responsive parkinsonism, and severe levodopa-induced dyskinesia was observed in the patient carrying the LRRK2 and parkin mutations. There was notable variability in ages of the disease onset in G2019S carriers not explained by APOE genotypes. Two subsets of G2019S-positive patients had different PARK8 haplotypes suggesting that the LRRK2 G2019S in Russian patients had arisen independently on different chromosomes. Identification of common LRRK2 mutations in some PD patients without an overt family history has notable implications for genetic counseling. SN - 1468-1331 UR - https://www.unboundmedicine.com/medline/citation/17388990/A_common_leucine_rich_repeat_kinase_2_gene_mutation_in_familial_and_sporadic_Parkinson's_disease_in_Russia_ L2 - https://doi.org/10.1111/j.1468-1331.2007.01685.x DB - PRIME DP - Unbound Medicine ER -